XML 22 R78.htm IDEA: XBRL DOCUMENT v2.4.0.8
DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Organization And Accounting Policies [Line Items]      
Maximum Investment Percentage, Fair Value 20.00%    
Percentage of LIFO Inventory 12.00%    
Senior Notes $ 400,000,000    
Convertible Debt 60,200,000    
Debt Instrument, Fair Value Disclosure 418,000,000    
Equity Method Investments 0 0  
Research and Development Expense 11,165,000 7,148,000 4,228,000
Advertising Expense 2,000,000 2,000,000 2,000,000
Deposits, Foreign 121,700,000 84,800,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 60,000 45,000 492,500
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 225,750 293,000  
Building and Building Improvements [Member]
     
Organization And Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life, Maximum 40 years 25 years  
Machinery and Equipment [Member]
     
Organization And Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life, Maximum 20 years 10 years  
Tools, Dies and Molds [Member]
     
Organization And Accounting Policies [Line Items]      
Property, Plant and Equipment, Useful Life, Maximum 9 years 5 years  
Senior Secured Notes 6.875 Percent [Member]
     
Organization And Accounting Policies [Line Items]      
Debt Instrument, Interest Rate, Stated Percentage 6.875%    
Senior Notes 400,000,000 0  
5.625% convertible senior subordinated notes [Member]
     
Organization And Accounting Policies [Line Items]      
Debt Instrument, Interest Rate, Stated Percentage 5.625%    
Convertible Debt 60,161,000 112,881,000  
Wheels India [Member]
     
Organization And Accounting Policies [Line Items]      
Equity Method Investments 44,541,000 37,115,000  
Equity Method Investment, Ownership Percentage 41.73%    
Equity Method Investment, Quoted Market Value $ 52,900,000